Accelagen is a fast growing Gene-to-Protein company providing superior quality services and products. The Accelagen team has demonstrated independent research capability in many projects and provided innovative solutions. Our scientists have extensive experiences in production of antibodies, GPCRs, kinases, nuclear receptors, and many other classes of drug targets and therapeutic proteins. Accelagen has established an unsurpassed track record of timely completion of projects over the years.Accelagen contract services provide a comprehensive gene-to-protein solution. Our recombinant protein expression and purification services have yielded premium quality recombinant proteins for drug discovery. We have produced recombinant proteins for determination of co-crystal structures in Structure-Based Drug Discovery (SBDD), for assays in high-throughput screening (HTS) and lead development, and for pre-clinical animal studies.Accelagen’s gene-to-protein platform integrates the latest technologies of Baculovirus Expression Vector System (BEVS), E. coli expression, mammalian expression, Wave Bioreactors, Cell Factory, and AKTA chromatography systems for protein purification. We have achieved superior protein quality and accelerated the processes from gene to protein. This platform is validated in the quality of our products and by the successes of our customers.

Transgenic expression and purification of skeletal muscle myosin II isoforms using the Drosophila melanogaster indirect flight muscle system for X-ray Crystallography.

Chemistry labs, CHEM 100, CHEM 200

Chair-Elect shall succeed to the office of Chair at the completion of the term (1 year).

Chemistry lab, CHEM 6BL